Diagnosed with ULMS, Abdominal Cancer, or Uterine Cancer?
If you or a loved one was diagnosed with cancer after undergoing surgery performed using a power morcellator device, you may be entitled to compensation. Morcellators have been linked to an increased risk of uterine leiomyosarcoma (ULMS), uterine cancer, and abdominal cancer in patients who undergo myomectomy, hysterectomy, or uterine fibroid surgical procedures using this medical device.
You can find out more about power morcellators and your legal rights by calling Crumley Roberts for a free consultation. Our phone lines are open 24 hours a day, 7 days a week and we are always happy to answer your questions. Our medical device injury attorneys are here to help take away the worry. We know your life has been turned upside down, and we want to help you face a brighter future.
Currently Accepting Morcellator Cancer Cases
Our firm is investigating cases of cancer that may be linked to morcellators. Many patients opt for or are recommended to undergo morcellator surgery because it is minimally invasive and allows patients to heal more quickly. Unfortunately, recent studies have indicated that when surgeons use morcellators in uterine surgery, previously undetected cancerous uterine fibroid tissue may be liquefied, allowing cancer to spread throughout a patient’s abdominal cavity. This can result in metastization and new, life-threatening tumors.
Patients with undetected uterine sarcoma, a type of cancer that includes uterine leiomyosarcoma (LMS), may be at risk when undergoing hysterectomy or myomectomy procedures.
At Crumley Roberts, We Treat Clients Like Family
When you come to Crumley Roberts, you become a part of our family. Should you become our client, we will put your interests first as we handle your morcellator lawsuit. We’re here to help you through this difficult time.
You can learn more about morcellator cancer and how we can help by calling (828) 597-0163. We look forward to hearing from you.